Human cancers with a high frequency microsatellite instability phenotype develop due to defects in DNA mismatch repair genes. Silencing of a DNA mismatch repair gene, hMLH1 gene, by promoter hypermethylation is a frequent cause of the microsatellite instability-H phenotype. Using methylation specific PCR we investigated the methylation status of the hMLH1 gene promoter in 17 solitary gastric cancers (12 microsatellite instability-H and five microsatellite stable tumours from 17 patients), and 13 multiple gastric cancers (eight microsatellite instability-H, one low frequency microsatellite instability-L and four microsatellite stable tumours from five patients) and also examined non-cancerous gastric mucosa both adjacent to and distant from each tumour. Expression of hMLH1 protein was evaluated by immunohistochemistry. All microsatellite instability-H tumours (20 out of 20) had evidence of methylation of hMLH1 promoter, whereas only one out of 10 microsatellite instability-L and microsatellite stable tumours did (P50.0000005), and the methylation status correlated with hMLH1 protein expression (P50.000003). Furthermore, methylation of the hMLH1 promoter was detected in 50% (6 out of 12) and 63% (5 out of 8) of non-cancerous gastric mucosa samples adjacent to, and in 33% (4 out of 12) and 40% (2 out of 5) of those obtained from distant portion of, solitary and multiple cancers with microsatellite instability-H. Thus both solitary and multiple gastric cancers with microsatellite instability-H have evidence of similar high levels of hMLH1 promoter hypermethylation in the surrounding non-cancerous tissue. Hypermethylation of the hMLH1 promoter occurs in non-cancerous gastric mucosa of microsatellite instability-H tumours and may increase the risk of subsequent neoplasia. British Journal of Cancer (2002) Microsatellite instability (MSI) due to defects in mismatch repair genes such as hMLH1 and hMSH2 is now widely recognized as an important mechanism in tumorigenesis (Aaltonen et al, 1993;Ionov et al, 1993;Thibodeau et al, 1996;Fleisher et al, 1999;Kang et al, 1999;Leung et al, 1999;Suzuki et al, 1999;Toyota et al, 1999a). MSI is reportedly present in 15 -33% of solitary gastric cancers, although mutations of the hMLH1 or hMSH2 genes are rare in sporadic gastric cancers (Chong et al, 1994;Mironov et al, 1994;Strickler et al, 1994;Tamura et al, 1996). Hypermethylation of promoter region CpG islands is a common mechanism by which tumour suppressor or tumour-related genes, and DNA mismatch repair genes are inactivated (Herman et al, 1995Kane et al, 1997;Baylin et al, 1998;Jones and Laird, 1999). Aberrant DNA methylation of promoter region CpG islands of several genes, including retinoblastoma (Rb), von Hippel-Lindau (VHL), p16, p15, APC, E-cadherin and hMLH1 has been reported in human cancers, and silencing of hMLH1 by promoter hypermethylation is the major causative event in the development of human cancers with MSI phenotype, including gastric cancers (Graff et al, 1997;Kane et al, 1997;Herman et al, 1998;Fleisher et a...